{
  "abstract": "Background\n\nLeft atrial enlargement (LAE) is common in patients undergoing transcatheter aortic valve implantation (TAVI), but its prognostic significance may vary according to the clinical drivers of atrial remodeling. We examined whether prognostic factors differ by clinically attributed LAE subtype in patients undergoing TAVI with preserved left ventricular ejection fraction (LVEF).Methods and results\n\nWe retrospectively analyzed 317 consecutive patients with symptomatic severe aortic stenosis (AS) undergoing TAVI who had preserved LVEF and LAE. Patients were classified as AS-associated LAE (no atrial fibrillation [AF] and <moderate mitral regurgitation [MR]) or AF/MR-associated LAE (AF and/or ≥moderate MR). The primary endpoint was all-cause death. During a median follow-up of 2.7 years, 69 patients (21.8%) died. The all-cause mortality rate was higher in the AF/MR-associated group than in the AS-associated LAE group (30.7% vs. 19.0%; log-rank P<0.01), but this association was attenuated after adjustment for eGFR, log-BNP, and LAVI. In the AS-associated LAE group, higher log-BNP (hazard ratio (HR) 1.45, 95% confidence interval (CI) 1.06-1.98), higher E/e' (HR 1.03, 95% CI 1.01-1.06), and lower TAPSE (HR 0.89, 95% CI 0.81-0.99) predicted death. In the AF/MR-associated LAE group, lower eGFR (HR 0.96, 95% CI 0.93-1.00) and higher log-BNP (HR 1.98, 95% CI 1.09-3.59) predicted death after adjustment for age. Interactions were significant for eGFR and E/e'.Conclusions\n\nPrognostic markers after TAVI differ by clinically attributed LAE subtype, supporting subtype-informed risk stratification.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Cardiovascular Medicine, Osaka Metropolitan University Graduate School of Medicine Osaka Japan."
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 16,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Tatsuya Sato"
    },
    {
      "affs": [
        0
      ],
      "name": "Asahiro Ito"
    },
    {
      "affs": [
        0
      ],
      "name": "Yuki Kitagawa"
    },
    {
      "affs": [
        0
      ],
      "name": "Shinji Ito"
    },
    {
      "affs": [
        0
      ],
      "name": "Hiroki Yamaura"
    },
    {
      "affs": [
        0
      ],
      "name": "Akihiro Okamoto"
    },
    {
      "affs": [
        0
      ],
      "name": "Nanaka Nomura"
    },
    {
      "affs": [
        0
      ],
      "name": "Tomohiro Yamaguchi"
    },
    {
      "affs": [
        0
      ],
      "name": "Shunsuke Kagawa"
    },
    {
      "affs": [
        0
      ],
      "name": "Mana Ogawa"
    },
    {
      "affs": [
        0
      ],
      "name": "Takenobu Shimada"
    },
    {
      "affs": [
        0
      ],
      "name": "Sera Ishikawa"
    },
    {
      "affs": [
        0
      ],
      "name": "Yusuke Hayashi"
    },
    {
      "affs": [
        0
      ],
      "name": "Atsushi Shibata"
    },
    {
      "affs": [
        0
      ],
      "name": "Kenichiro Otsuka"
    },
    {
      "affs": [
        0
      ],
      "name": "Daiju Fukuda"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/4htsgsfpd1xkh.bib",
  "cited_by": 0,
  "doi": "10.1253/circrep.cr-26-0181",
  "fulltext_url": "https://europepmc.org/articles/PMC13747992",
  "id": "4htsgsfpd1xkh",
  "issns": [
    "2434-0790"
  ],
  "landing_url": "https://europepmc.org/article/MED/43011164",
  "language": "eng",
  "licence": "CC-BY-NC-ND",
  "licence_label": "CC BY-NC-ND",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Original Article"
    ],
    [
      "heading",
      "Valvular Heart Disease"
    ],
    [
      "openalex",
      "2705|Cardiac Valve Diseases and Treatments"
    ]
  ],
  "openalex": "W7204919514",
  "pdf_url": "https://europepmc.org/articles/PMC13747992?pdf=render",
  "pmcid": "PMC13747992",
  "pmid": "43011164",
  "published": "2026-09-02",
  "publisher": "The Japanese Circulation Society",
  "ris": "https://research.draconitic.com/paper/4htsgsfpd1xkh.ris",
  "sources": [
    {
      "first_seen": "2026-11-12T15:25:13Z",
      "native_id": "MED:43011164",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/43011164"
    },
    {
      "first_seen": "2026-11-13T12:25:34Z",
      "native_id": "PMC13747992",
      "source": "pmc",
      "url": "https://doi.org/10.1253/circrep.cr-26-0181"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2705|Cardiac Valve Diseases and Treatments",
      "subfield": "cardiovascular"
    }
  ],
  "title": "Prognostic Implications of Clinically Attributed Left Atrial Enlargement Subtypes in Patients Undergoing Transcatheter Aortic Valve Implantation.",
  "title_text": "Prognostic Implications of Clinically Attributed Left Atrial Enlargement Subtypes in Patients Undergoing Transcatheter Aortic Valve Implantation.",
  "type": "peer-reviewed",
  "updated_at": "2026-11-14T12:21:03Z",
  "url": "https://research.draconitic.com/paper/4htsgsfpd1xkh",
  "venue": "Circulation reports",
  "versions": []
}